nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR5—epilepsy syndrome	0.447	0.569	CbGaD
Vapreotide—SSTR2—epilepsy syndrome	0.339	0.431	CbGaD
Vapreotide—TACR1—vagus nerve—epilepsy syndrome	0.0121	0.187	CbGeAlD
Vapreotide—SSTR5—hindbrain—epilepsy syndrome	0.0083	0.128	CbGeAlD
Vapreotide—SSTR2—hindbrain—epilepsy syndrome	0.00535	0.0822	CbGeAlD
Vapreotide—SSTR5—brainstem—epilepsy syndrome	0.00475	0.0731	CbGeAlD
Vapreotide—TACR1—ganglion—epilepsy syndrome	0.00468	0.0721	CbGeAlD
Vapreotide—SSTR2—brainstem—epilepsy syndrome	0.00306	0.0471	CbGeAlD
Vapreotide—SSTR2—forebrain—epilepsy syndrome	0.00296	0.0455	CbGeAlD
Vapreotide—SSTR2—telencephalon—epilepsy syndrome	0.00272	0.0418	CbGeAlD
Vapreotide—SSTR5—cerebellum—epilepsy syndrome	0.00234	0.0361	CbGeAlD
Vapreotide—TACR1—brainstem—epilepsy syndrome	0.00204	0.0313	CbGeAlD
Vapreotide—TACR1—forebrain—epilepsy syndrome	0.00197	0.0302	CbGeAlD
Vapreotide—TACR1—telencephalon—epilepsy syndrome	0.00181	0.0278	CbGeAlD
Vapreotide—SSTR2—head—epilepsy syndrome	0.00169	0.026	CbGeAlD
Vapreotide—SSTR2—nervous system—epilepsy syndrome	0.00161	0.0247	CbGeAlD
Vapreotide—SSTR2—central nervous system—epilepsy syndrome	0.00155	0.0238	CbGeAlD
Vapreotide—SSTR2—cerebellum—epilepsy syndrome	0.00151	0.0232	CbGeAlD
Vapreotide—TACR1—spinal cord—epilepsy syndrome	0.00127	0.0195	CbGeAlD
Vapreotide—SSTR2—brain—epilepsy syndrome	0.00123	0.0189	CbGeAlD
Vapreotide—TACR1—head—epilepsy syndrome	0.00113	0.0173	CbGeAlD
Vapreotide—Octreotide—SSTR4—epilepsy syndrome	0.00109	0.157	CrCbGaD
Vapreotide—TACR1—nervous system—epilepsy syndrome	0.00107	0.0164	CbGeAlD
Vapreotide—TACR1—central nervous system—epilepsy syndrome	0.00103	0.0158	CbGeAlD
Vapreotide—Pasireotide—SSTR5—epilepsy syndrome	0.000949	0.136	CrCbGaD
Vapreotide—Pasireotide—SSTR1—epilepsy syndrome	0.000846	0.121	CrCbGaD
Vapreotide—Pasireotide—SSTR3—epilepsy syndrome	0.000846	0.121	CrCbGaD
Vapreotide—TACR1—brain—epilepsy syndrome	0.000815	0.0125	CbGeAlD
Vapreotide—Pasireotide—SSTR2—epilepsy syndrome	0.000719	0.103	CrCbGaD
Vapreotide—Octreotide—SSTR5—epilepsy syndrome	0.000705	0.101	CrCbGaD
Vapreotide—Octreotide—SSTR3—epilepsy syndrome	0.000629	0.0899	CrCbGaD
Vapreotide—Octreotide—SSTR1—epilepsy syndrome	0.000629	0.0899	CrCbGaD
Vapreotide—Octreotide—SSTR2—epilepsy syndrome	0.000535	0.0764	CrCbGaD
Vapreotide—Desmopressin—PTGS2—epilepsy syndrome	4.15e-05	0.00594	CrCbGaD
Vapreotide—TACR1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.14e-05	0.000221	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.13e-05	0.00022	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—OPRM1—epilepsy syndrome	3.13e-05	0.00022	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GRM8—epilepsy syndrome	3.1e-05	0.000217	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PGF—epilepsy syndrome	3.1e-05	0.000217	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR2—epilepsy syndrome	3.09e-05	0.000217	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—SST—epilepsy syndrome	3.09e-05	0.000217	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CDC42—epilepsy syndrome	3.07e-05	0.000216	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.06e-05	0.000215	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GABBR1—epilepsy syndrome	3.06e-05	0.000215	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—epilepsy syndrome	3.03e-05	0.000213	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.02e-05	0.000212	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR5—epilepsy syndrome	3.02e-05	0.000212	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AVP—epilepsy syndrome	2.97e-05	0.000209	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—epilepsy syndrome	2.97e-05	0.000208	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR3—epilepsy syndrome	2.95e-05	0.000207	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNAO1—epilepsy syndrome	2.95e-05	0.000207	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—OPRD1—epilepsy syndrome	2.95e-05	0.000207	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.95e-05	0.000207	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HRH3—epilepsy syndrome	2.93e-05	0.000206	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.92e-05	0.000205	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.9e-05	0.000204	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.9e-05	0.000204	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—OPRM1—epilepsy syndrome	2.89e-05	0.000203	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NPY—epilepsy syndrome	2.88e-05	0.000202	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ATP2A2—epilepsy syndrome	2.88e-05	0.000202	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CNR1—epilepsy syndrome	2.85e-05	0.0002	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.84e-05	0.0002	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PDYN—epilepsy syndrome	2.83e-05	0.000199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CHRM1—epilepsy syndrome	2.83e-05	0.000199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GRM1—epilepsy syndrome	2.83e-05	0.000199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR7—epilepsy syndrome	2.83e-05	0.000199	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGT—epilepsy syndrome	2.8e-05	0.000197	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR5—epilepsy syndrome	2.78e-05	0.000196	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HTR7—epilepsy syndrome	2.78e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL3—epilepsy syndrome	2.78e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CRH—epilepsy syndrome	2.78e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL2—epilepsy syndrome	2.78e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—OXT—epilepsy syndrome	2.78e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HSPB1—epilepsy syndrome	2.78e-05	0.000195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR5—epilepsy syndrome	2.74e-05	0.000192	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR3—epilepsy syndrome	2.73e-05	0.000191	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.73e-05	0.000191	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.7e-05	0.00019	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HTR2A—epilepsy syndrome	2.68e-05	0.000188	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.66e-05	0.000187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GAL—epilepsy syndrome	2.66e-05	0.000187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GFAP—epilepsy syndrome	2.66e-05	0.000187	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NPY—epilepsy syndrome	2.66e-05	0.000187	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ATP2A2—epilepsy syndrome	2.66e-05	0.000187	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT3—epilepsy syndrome	2.65e-05	0.000186	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GRM5—epilepsy syndrome	2.63e-05	0.000185	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP2—epilepsy syndrome	2.63e-05	0.000185	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CHRM3—epilepsy syndrome	2.63e-05	0.000185	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.59e-05	0.000182	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGT—epilepsy syndrome	2.59e-05	0.000182	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSC1—epilepsy syndrome	2.58e-05	0.000181	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTK2B—epilepsy syndrome	2.58e-05	0.000181	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AVP—epilepsy syndrome	2.58e-05	0.000181	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HSPB1—epilepsy syndrome	2.56e-05	0.00018	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL2—epilepsy syndrome	2.56e-05	0.00018	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—OXT—epilepsy syndrome	2.56e-05	0.00018	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CRH—epilepsy syndrome	2.56e-05	0.00018	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL3—epilepsy syndrome	2.56e-05	0.00018	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGT—epilepsy syndrome	2.54e-05	0.000179	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR5—epilepsy syndrome	2.53e-05	0.000178	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.52e-05	0.000177	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SST—epilepsy syndrome	2.51e-05	0.000176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR2—epilepsy syndrome	2.51e-05	0.000176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NTRK2—epilepsy syndrome	2.51e-05	0.000176	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—DUSP6—epilepsy syndrome	2.49e-05	0.000175	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.48e-05	0.000174	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CHRM2—epilepsy syndrome	2.48e-05	0.000174	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.48e-05	0.000174	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HTR2A—epilepsy syndrome	2.47e-05	0.000174	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRA2A—epilepsy syndrome	2.46e-05	0.000173	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PLAT—epilepsy syndrome	2.45e-05	0.000172	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CDC42—epilepsy syndrome	2.42e-05	0.00017	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GABBR1—epilepsy syndrome	2.41e-05	0.000169	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.39e-05	0.000168	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSC1—epilepsy syndrome	2.38e-05	0.000167	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTK2B—epilepsy syndrome	2.38e-05	0.000167	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BDKRB2—epilepsy syndrome	2.36e-05	0.000166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL12—epilepsy syndrome	2.36e-05	0.000166	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—epilepsy syndrome	2.36e-05	0.000166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PRKCB—epilepsy syndrome	2.35e-05	0.000165	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGT—epilepsy syndrome	2.35e-05	0.000165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6ST—epilepsy syndrome	2.34e-05	0.000164	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AVP—epilepsy syndrome	2.34e-05	0.000164	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUNB—epilepsy syndrome	2.32e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CNR1—epilepsy syndrome	2.32e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR2—epilepsy syndrome	2.32e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SST—epilepsy syndrome	2.32e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NTRK2—epilepsy syndrome	2.32e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PLCB1—epilepsy syndrome	2.31e-05	0.000162	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HRH3—epilepsy syndrome	2.31e-05	0.000162	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—DUSP6—epilepsy syndrome	2.3e-05	0.000161	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—OPRM1—epilepsy syndrome	2.27e-05	0.00016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRA2A—epilepsy syndrome	2.27e-05	0.000159	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HTR7—epilepsy syndrome	2.26e-05	0.000159	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PLAT—epilepsy syndrome	2.26e-05	0.000159	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HBEGF—epilepsy syndrome	2.2e-05	0.000154	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.19e-05	0.000154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BDKRB2—epilepsy syndrome	2.18e-05	0.000153	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL12—epilepsy syndrome	2.18e-05	0.000153	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—epilepsy syndrome	2.18e-05	0.000153	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PRKCB—epilepsy syndrome	2.17e-05	0.000152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6ST—epilepsy syndrome	2.16e-05	0.000152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT3—epilepsy syndrome	2.16e-05	0.000151	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR3—epilepsy syndrome	2.15e-05	0.000151	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.15e-05	0.000151	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—epilepsy syndrome	2.14e-05	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CNR1—epilepsy syndrome	2.14e-05	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUNB—epilepsy syndrome	2.14e-05	0.00015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PLCB1—epilepsy syndrome	2.13e-05	0.00015	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADAM10—epilepsy syndrome	2.11e-05	0.000148	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—epilepsy syndrome	2.1e-05	0.000147	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPY—epilepsy syndrome	2.09e-05	0.000147	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.09e-05	0.000147	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HTR7—epilepsy syndrome	2.09e-05	0.000147	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGT—epilepsy syndrome	2.04e-05	0.000143	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HBEGF—epilepsy syndrome	2.03e-05	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CRH—epilepsy syndrome	2.02e-05	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL2—epilepsy syndrome	2.02e-05	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—OXT—epilepsy syndrome	2.02e-05	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HSPB1—epilepsy syndrome	2.02e-05	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL3—epilepsy syndrome	2.02e-05	0.000142	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR5—epilepsy syndrome	1.99e-05	0.00014	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—S100B—epilepsy syndrome	1.99e-05	0.00014	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT3—epilepsy syndrome	1.99e-05	0.00014	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—epilepsy syndrome	1.98e-05	0.000139	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SOCS3—epilepsy syndrome	1.97e-05	0.000138	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDC42—epilepsy syndrome	1.97e-05	0.000138	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.95e-05	0.000137	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADAM10—epilepsy syndrome	1.94e-05	0.000136	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—epilepsy syndrome	1.93e-05	0.000136	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AVP—epilepsy syndrome	1.9e-05	0.000134	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.88e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.88e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSC1—epilepsy syndrome	1.88e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGT—epilepsy syndrome	1.85e-05	0.00013	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—S100B—epilepsy syndrome	1.84e-05	0.000129	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR2—epilepsy syndrome	1.83e-05	0.000128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SST—epilepsy syndrome	1.83e-05	0.000128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.83e-05	0.000128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SOCS3—epilepsy syndrome	1.82e-05	0.000128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDC42—epilepsy syndrome	1.81e-05	0.000127	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.81e-05	0.000127	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HES1—epilepsy syndrome	1.8e-05	0.000126	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.79e-05	0.000125	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PLAT—epilepsy syndrome	1.78e-05	0.000125	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AVP—epilepsy syndrome	1.76e-05	0.000123	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FYN—epilepsy syndrome	1.75e-05	0.000123	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—H2AFX—epilepsy syndrome	1.74e-05	0.000122	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MEF2C—epilepsy syndrome	1.74e-05	0.000122	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.72e-05	0.000121	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.72e-05	0.000121	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.71e-05	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.71e-05	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.7e-05	0.000119	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUNB—epilepsy syndrome	1.68e-05	0.000118	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CNR1—epilepsy syndrome	1.68e-05	0.000118	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—YWHAZ—epilepsy syndrome	1.68e-05	0.000118	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.68e-05	0.000118	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NGF—epilepsy syndrome	1.66e-05	0.000117	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HES1—epilepsy syndrome	1.66e-05	0.000117	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HTR7—epilepsy syndrome	1.64e-05	0.000115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR5—epilepsy syndrome	1.62e-05	0.000114	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FYN—epilepsy syndrome	1.62e-05	0.000113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—H2AFX—epilepsy syndrome	1.61e-05	0.000113	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MEF2C—epilepsy syndrome	1.61e-05	0.000113	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.6e-05	0.000112	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HTR2A—epilepsy syndrome	1.58e-05	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT3—epilepsy syndrome	1.57e-05	0.00011	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—epilepsy syndrome	1.56e-05	0.000109	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.55e-05	0.000109	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NGF—epilepsy syndrome	1.54e-05	0.000108	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.53e-05	0.000107	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—epilepsy syndrome	1.52e-05	0.000107	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TSC2—epilepsy syndrome	1.5e-05	0.000106	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGT—epilepsy syndrome	1.5e-05	0.000106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR5—epilepsy syndrome	1.49e-05	0.000105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APOE—epilepsy syndrome	1.47e-05	0.000103	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HTR2A—epilepsy syndrome	1.46e-05	0.000103	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—S100B—epilepsy syndrome	1.45e-05	0.000102	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—epilepsy syndrome	1.44e-05	0.000101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.43e-05	0.000101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDC42—epilepsy syndrome	1.43e-05	0.0001	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCB—epilepsy syndrome	1.39e-05	9.75e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TSC2—epilepsy syndrome	1.39e-05	9.75e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGT—epilepsy syndrome	1.39e-05	9.74e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6ST—epilepsy syndrome	1.38e-05	9.71e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AVP—epilepsy syndrome	1.38e-05	9.71e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APOE—epilepsy syndrome	1.36e-05	9.54e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—epilepsy syndrome	1.33e-05	9.35e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HES1—epilepsy syndrome	1.31e-05	9.19e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCB—epilepsy syndrome	1.28e-05	9e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6ST—epilepsy syndrome	1.28e-05	8.96e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FYN—epilepsy syndrome	1.27e-05	8.93e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.27e-05	8.9e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—epilepsy syndrome	1.27e-05	8.88e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.27e-05	8.88e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—epilepsy syndrome	1.24e-05	8.69e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.22e-05	8.59e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NGF—epilepsy syndrome	1.21e-05	8.49e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR5—epilepsy syndrome	1.18e-05	8.26e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—epilepsy syndrome	1.17e-05	8.2e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.15e-05	8.08e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—epilepsy syndrome	1.14e-05	8.02e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF2—epilepsy syndrome	1.12e-05	7.86e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TSC2—epilepsy syndrome	1.09e-05	7.68e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGT—epilepsy syndrome	1.09e-05	7.67e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APOE—epilepsy syndrome	1.07e-05	7.51e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—epilepsy syndrome	1.05e-05	7.36e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RELA—epilepsy syndrome	1.04e-05	7.29e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF2—epilepsy syndrome	1.03e-05	7.25e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MTOR—epilepsy syndrome	1.02e-05	7.15e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.01e-05	7.09e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.01e-05	7.06e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RELA—epilepsy syndrome	9.58e-06	6.73e-05	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—epilepsy syndrome	9.45e-06	6.64e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MTOR—epilepsy syndrome	9.4e-06	6.6e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—epilepsy syndrome	9.37e-06	6.58e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—epilepsy syndrome	9.19e-06	6.46e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUN—epilepsy syndrome	9.1e-06	6.39e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—epilepsy syndrome	8.99e-06	6.32e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—epilepsy syndrome	8.85e-06	6.22e-05	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—epilepsy syndrome	8.72e-06	6.13e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—epilepsy syndrome	8.64e-06	6.07e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—epilepsy syndrome	8.59e-06	6.03e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUN—epilepsy syndrome	8.4e-06	5.9e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—epilepsy syndrome	8.17e-06	5.74e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SRC—epilepsy syndrome	8.16e-06	5.73e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF2—epilepsy syndrome	8.13e-06	5.71e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—epilepsy syndrome	7.95e-06	5.58e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—epilepsy syndrome	7.92e-06	5.56e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RELA—epilepsy syndrome	7.55e-06	5.3e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SRC—epilepsy syndrome	7.53e-06	5.29e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MTOR—epilepsy syndrome	7.4e-06	5.2e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—epilepsy syndrome	7.34e-06	5.15e-05	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.87e-06	4.82e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—epilepsy syndrome	6.81e-06	4.78e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUN—epilepsy syndrome	6.61e-06	4.64e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—epilepsy syndrome	6.43e-06	4.52e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—epilepsy syndrome	6.24e-06	4.38e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SRC—epilepsy syndrome	5.93e-06	4.16e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—epilepsy syndrome	5.78e-06	4.06e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—epilepsy syndrome	5.07e-06	3.56e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—epilepsy syndrome	4.68e-06	3.29e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—epilepsy syndrome	3.68e-06	2.59e-05	CbGpPWpGaD
